The increase in VEGF expression leads to autocrine binding of VEGFR2 and subsequent activation of downstream angiogenic signaling pathways, suggesting that VEGF expression contributes to a feed-forward pathway promoting the CCM pathologic phenotype. The gene discussed is VEGFA; the disease is cerebral cavernous malformation.